9th Edition – Science by Women

The Women for Africa Foundation (FMxA), in line with its mission of contributing to the development of Africa through the drive of its women, is launching the 9th Edition of SCIENCE BY WOMEN programme, with the aim to promote African women’s leadership in scientific research and technology transfer and to foster the capacity of the research centres in their home countries. The main goal is to enable African women researchers and scientists to tackle the great challenges faced by Africa through research in health and biomedicine, sustainable agriculture and food security, water, energy and climate change. Women’s lives are significantly affected by the repercussions of uncontrolled development; however, social, structural and economic barriers limit their capacity to tackle the great challenges faced by the continent. The gender disparities in science and technology in both the public and private spheres affect Africa’s population as a whole. Narrowing this gap, which has severe consequences on the balanced and sustainable development of African countries, is vital to achieve long-term progress and equal growing.

Applications closing deadline: September 30, 2023

For more information, click: https://mujeresporafrica.es/9th-edition-science-by-women/

 

IBD Plexus: Academic Request for Proposals

The Crohn’s & Colitis Foundation is excited to release an international request for proposals (RFP) for academic researchers to gain access to IBD patients’ biosamples and / or research-ready datasets housed within IBD Plexus®. The Foundation seeks research proposals that would utilize IBD Plexus biosamples and / or data to facilitate efforts in 4 main areas: 1) identification and / or validation of diagnostics / biomarkers, 2) therapeutic development and optimization 3) disease management 4) disease prevention

Applications closing deadline: Not specified; Proposal Review timelines: October and December 2023

For more information, click: https://www.crohnscolitisfoundation.org/research/grants-fellowships/ibd-plexus

 Call for proposals: Case studies to advance research on climate change adaptation strategies and their impact on public health

As part of the NIH Climate Change and Health Initiative and in collaboration with partner NIH Institutes and Centers, the Center for Global Health Studies (CGHS) of the Fogarty International Center (FIC) within the U.S. National Institutes of Health (NIH) is inviting submissions for a collection of case studies on adaptation strategies that respond to the impact of climate change on public health. For the purposes of this call, adaptation is broadly defined as the process of adjustment to actual and potential climate-led impacts. A case study approach is particularly useful when there is a need to explore in-depth information of a topic or event, identify gaps in current literature, and lessons learnt in multiple settings. This collection is intended to shed light on current knowledge and the potential for research to increase our understanding of climate change adaptation and its impact on health. For instance, research is needed to:

• Increase our knowledge of evidence-based adaptation strategies that impact health;
• Support the use of innovative research approaches which incorporate quantitative and/or qualitative assessments to better understand the impact of climate adaptation strategies on health outcomes;
• Increase our understanding of the impacts of climate change adaptation on health among populations disproportionately impacted by climate change, including those in low- and middle-income countries (LMICs) and under-resourced and marginalized populations globally;
• Encourage use of implementation science methodologies to translate adaptation strategies promote the uptake, scale-up, and spread across different contexts; and
• Increase opportunities to strengthen climate and health research capacity and support scholars from LMICs to study climate adaptation and health and publish their results.

Applications closing deadline: October 16, 2023

For more information, click: https://www.fic.nih.gov/About/center-global-health-studies/Pages/climate-change-call-for-proposals.aspx?utm_source=funding-news&utm_medium=email&utm_campaign=funding-news

 

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research.  Applications may propose studies using either single or mixed methods.  Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.

Applications closing deadline: October 19, 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-20-254.html

 

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research.  These applications should propose single or mixed methods studies that break new ground, extend previous discoveries in new directions or develop preliminary data in preparation for larger studies. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.

Applications closing deadline: October 19, 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/par-20-255.html

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites Small Research Grant (R03) applications to study the ethical, legal and social implications (ELSI) of human genome research.  These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data.

Applications closing deadline: October 19, 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/par-20-257.html

 

Primary Care-Based Screening Tool and Intervention Development for the Detection and Prevention of Abuse and Neglect in Older and Vulnerable Adults With, or at Risk for, Mild Cognitive Impairment and AD/ADRD (R61/R33 Clinical Trial Required)

The purpose of this Notice of Funding Opportunity (NOFO) is to support research that can lead to the development of primary care-based screening tools and early interventions to detect and prevent abuse and neglect (hereafter referred to as “AN”) in older and vulnerable adults living with, or at risk for, mild cognitive impairment (MCI) and Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). In the interest of supporting early-stage research conducted by interdisciplinary teams that can lead to the development of screening tools and behavioral interventions that can be successfully implemented in primary care settings with diverse patient populations, this NOFO invites five-year, R61/R33 phased award applications. The R61 planning and pilot phase will provide up to two years of funding to support Stage I and Stage III research to develop, modify, and/or adapt, as well as pilot test screening tools and/or behavioral interventions. The R33 implementation phase will provide up to three years of additional funding to support a Stage III, preliminary efficacy study in primary care and primary care-referable settings.

Applications closing deadline: 20 October 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-048.html

German-African Cooperation Projects in Infectiology

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) calls for draft proposals of joint research projects between researchers in Germany and Africa.

The scope of the call includes:

• The investigation of neglected tropical infectious diseases in humans and animals including social and behavioural aspects. “Neglected” in this context means that for basic research into these diseases, only very limited funding is available.
• The establishment or strengthening of mutually beneficial equal partnerships that allow African researchers to investigate topics of local significance and that open up research opportunities in Africa for German researchers in the long term.
• Providing support and funding for the academic and professional careers of young African researchers in their home countries in order to contribute to building research capacities in Africa.
• Strengthening research networks within Africa, therefore, several African partners may participate in one project.

Applications closing deadline: 30 October 2023

For more information: https://www.dfg.de/en/research_funding/announcements_proposals/2023/info_wissenschaft_23_56/index.html

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution. This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development.

Applications closing deadline: 3 November 2023

For more information: https://grants.nih.gov/grants/guide/pa-files/par-21-251.html

 

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution. This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

Applications closing deadline: 3 November 2023

For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-21-252.html

 

Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to invite basic observational or experimental behavioral and/or social science R01 applications that test how intrapersonal and interpersonal mechanisms of behavior change interact with, influence, or are influenced by characteristics of social networks, with implications for health. Research supported through this NOFO will examine at least two levels of analysis: interpersonal processes and social network characteristics. Projects will identify targets for future social network health behavior change interventions across the lifespan, especially in populations in which they are currently largely underdeveloped and untested (e.g., populations in mid- to- late life). Basic research to develop, refine, or optimize measures (i.e., assays) of putative targets (e.g., intra/interpersonal mechanisms of behavior change and/or social network characteristics) is also supported by this NOFO.

Applications closing deadline: 3 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-025.html

 

Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) invites R34 applications to support the planning activities necessary to develop social network interventions to promote health across the lifespan, especially in populations in which they are currently largely underdeveloped and untested (such as populations in mid- and late-life). Applications suited to this R34 will focus on planning activities for social network interventions for which a target interpersonal process of behavior change or social network characteristic has already been identified. Planning activities are those activities that are expected to yield necessary and sufficient information to inform final decisions about a social network health behavior change intervention prior to instigation of a hypothesis-driven trial to test a social network intervention. Activities may include, but are not limited to, team-building, protocol development, piloting of systems for data collection and/or management, feasibility and acceptability testing, staff training, and establishing documentation procedures.

Applications closing deadline: 3 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-026.html

 

HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 – Clinical Trial Optional) This notice of funding opportunity (NOFO) seeks to support research aimed at holistic understanding of inter-individual or between-person differences in human pain conditions, focusing  on ‘Whole Person Health’ and enhancing pain treatment and management strategies towards personalized pain medicine. The goal of this NOFO is to support studies that focus on the collection of clinical and/or preclinical data to enable evidence-based modeling and understanding of inter-individual differences and/or heterogeneity of pain occurring with use of pain therapy/management, or with conditions such as a second pain condition, a comorbid health condition, a comorbid mental health condition, or conditions of use / misuse of opioids, alcohol or other substances.

Applications closing deadline: 7 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-021.html?utm_medium=email&utm_source=govdelivery  

 

Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit P20 planning grant applications for Climate Change and Health Research Centers (CCHRCs). This program will support the development of a transdisciplinary research environment to sustain a program of fundamental and applied research to examine the impacts of climate change on health and to develop action-oriented solutions to protect the health of individuals, communities, and nations from the hazards posed by climate change. This opportunity will allow development of new research teams collaborating with communities and other partners to develop projects that generate data that will build or expand research capacity across a range of thematic scientific areas in support of the four core elements of the NIH’s Initiative in climate heath research: health effects research, health equity, intervention research, and training and capacity building (https://www.nih.gov/sites/default/files/research-training/initiatives/climate-change/nih-climate-change-framework.pdf).

Applications closing deadline: 7 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-23-007.html

 

Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed)

The goal of this Notice of Funding Opportunity (NOFO) is to seek applications proposing a set of planning activities that will lay the groundwork for scientific projects aimed at using animal models and longitudinal research designs to elucidate mechanisms mediating the impact of the early-life social environment on neurobehavioral development and the risk for substance use disorders (SUD) and their comorbidities in adolescence and adulthood. This funding opportunity will support projects of limited scope focused on coordination of a multidisciplinary research team; development of the research framework, design, and approach; and activities that will establish feasibility, validity, and/or other technically qualifying results that, if successful, would support a competitive application for a larger-scale, definitive research project (e.g., R01).

Applications closing deadline: 9 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-019.html

 

Wellcome Mental Health Award: Understanding how anxiety- and trauma-related problems develop, persist and resolve

This award will fund researchers to investigate the causal mechanisms through which brain, body and environment interact over time in the development, persistence and resolution of anxiety- and trauma-related disorders. Knowing more about these mechanisms will help us find better ways to identify these problems and intervene at an early stage.

Applications closing deadline: 14 November 2023

For more information, click: https://wellcome.org/grant-funding/schemes/understanding-anxiety-and-trauma-related-problems#key-dates-de6f

AWS Health Equity Initiative

The AWS Health Equity Initiative will support applications that develop culturally responsive solutions to: 1) increase access to health services, 2) reduce disparities by addressing social determinants of health, 3) leverage data to promote equitable and inclusive systems of care, and 4) advance equity in diagnostics and screening.

Applications closing deadline: 15 November 2023

For more information, click: https://aws.amazon.com/government-education/nonprofits/global-social-impact/health-equity/

 

Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, piloting innovative, collaborative research projects with low- and middle-income country (LMIC) institutions/ scientists on brain and other nervous system-related function and disorders throughout life, relevant to LMICs. Research on the full spectrum of neuro-health, neurological, neuromuscular, sensory, neuropsychiatric, cognitive, behavioral and neurodevelopmental function and disorders may span the full range of science from basic to clinical to translation and implementation research. Scientists in LMIC institutions may partner with scientists in other LMIC institutions and/or U.S. institutions

Applications closing deadline: 15 November 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-319.html

 

Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)

This Funding Opportunity Announcement (FOA) encourages grant applications for the conduct of innovative, collaborative research projects with low- and middle-income country (LMIC) institutions/ scientists on brain and other nervous system function and disorders throughout life, relevant to LMICs. Research on neuro-health and neurological, neuromuscular, sensory, neuropsychiatric, cognitive, behavioral and neurodevelopmental function and disorders may span the full range of science from basic to clinical to translation and implementation research. Scientists in the United States (U.S.) or upper middle-income countries (UMICs) are eligible to partner with LMIC institutions. Scientists in UMICs may partner directly with scientists at other LMIC institutions with or without out a US partner.

Applications closing deadline: 15 November 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-311.html

Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) seeks to support multidisciplinary research teams with complementary expertise in HIV and pathobiology, pathophysiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will comprehensively interrogate fundamental biological mechanisms underlying HIV-associated comorbidities, co-infections, and complications relevant to the mission of the NIDDK and advance progress toward preventing or alleviating them.

Applications closing deadline: 15 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-039.html

 

Fanconi Anemia Research Fund (FARF)

The Fanconi Anemia Research Fund (FARF) seeks to fund interdisciplinary and translational research efforts that will lead to rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia (FA). Research proposals must address one or more of our research priorities:

Top Priority:

• To define the pathogenesis of cancers including head and neck and anogenital squamous cell carcinomas that affect persons with FA, and to develop strategies for early detection, prevention, treatment, and cure.

Additional Priorities:

• To understand how alteration of the FA genes and their products lead to the clinical manifestations of the disease.
• To determine the causes of bone marrow failure, myelodysplasia, and leukemia in individuals with FA, and to develop strategies to prevent, treat and cure these disorders.
• To identify practical and proactive management strategies that families and persons with FA can use to develop and maintain a high quality of life.
• To support the creation of shared resources, databases, and technologies for the international FA research community.

Letter of interest deadline: not specified

For more information, click: https://www.fanconi.org/explore/apply-for-grant-funding

Gilead

Gilead welcomes funding requests for innovative, high impact projects that relate to at least one of our core therapeutic areas: Our grantmaking in Africa focuses on the following therapeutic areas: HIV/AIDS; Viral Hepatitis. Within these therapeutic areas, we provide support for a broad range of activities, including: Disease awareness; Disease prevention; Professional education; Improving patient access to care; Improving quality of care; Increasing scientific capacity; Strengthening healthcare systems. Funding requests must be submitted a minimum of 8 weeks prior to the start of the activity. The typical grant review timeline can be up to 12 weeks. Formal notifications of all funding decisions are sent in writing by email to the contact listed on the grant application.

Applications closing deadline: Grant applications are accepted throughout the year.

For more information, click: https://www.gilead.com/purpose/giving/funding-requests/apply-africa

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U01) applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as initial tool development or the significant modification of existing tools for new applications. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process must be included.

Applications closing deadline: 17 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-015.html

 

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. To be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process must be included.

Applications closing deadline: 17 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-016.html

 

Data Integration and Statistical Analysis Methods (DISAM) (U01 Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) encourages applications for the Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) D43 program for institutional research training programs in low-and middle-income countries (LMICs, as defined by the World Bank classification system). Applications may be for collaborations between institutions in the U.S and an eligible LMIC or may involve just LMIC institutions if there is a previous track record of externally funded research and/or research training programs by the lead LMIC institution. The proposed institutional research training program is expected to sustainably strengthen the NCD research capacity of the LMIC institutions, and to train in-country experts to develop and conduct research on NCDs across the lifespan, with the long-range goal of developing and implementing evidence-based interventions relevant to their countries. Interdisciplinary research training that cuts across NCDs is encouraged.

Applications closing deadline: 20 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-005.html

 

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC³H-IN) Implementation Science Coordinating Center (UM2 Clinical Trial Optional)

This NOFO invites applications to participate in a research program cooperative agreement to support the Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC3H-IN). The Network will expand and/or improve successes achieved by PATC3H to new geographic settings with limited implementation science (IS) research capacity and/or risk populations who are poorly represented in international adolescent HIV research (e.g. sexual and gender minorities; commercial sex workers; drug users) and stimulate much needed IS research in a neglected area of public health significance: prevention of new HIV infections among adolescents at risk and the identification of, and linkage and retention to care of and long-term viral suppression among youth living with HIV in low-to-middle income countries (LMICs). These settings must have an HIV epidemic density defined by UNAIDS estimates as either a country 1) in which at least 200,000 people are living with HIV and the number has not decreased by more than 5% over the last 2 consecutive years of available data or 2) has an HIV incidence among youth ages 10 to 24 years of 0.01% or more.

Applications closing deadline: 6 December 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-24-009.html

 

HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)

The goals of this program are to support locally relevant research in critical areas of HIV-associated non-communicable diseases (NCDs) at Low- and Middle-Income Country (LMIC) Institutions, to enhance research capacity, and to build a network of researchers both within and across LMICs to address this critical burden. This initiative is expected to stimulate new research on the interplay between HIV and development of NCDs in persons living with HIV (PLWH). This includes exploratory studies to uncover the extent to which HIV infection influences the etiopathogenesis of the NCDs; and to identify and develop appropriate approaches for effective diagnosis, prevention, therapeutic interventions and integrated clinical care for PLWH with the comorbid conditions. Applicants should develop their studies in keeping with the NIH HIV/AIDS Research Priorities.

Applications closing deadline: 8 December 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-191.html

 

Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)

Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from underrepresented minority groups through basic mechanistic or translational studies to investigate how HIV interacts with health disparities to promote both non-AIDS and AIDS-defining cancer initiation, progression, and the resulting pathogenic disease sequelae.

Applications closing deadline: 15 December 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-057.html

Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to support Implementation Science for Cancer Control in People Living with HIV (PLWH) in Low- and Middle-Income Countries (LMICs) to accelerate the integration of evidence-based cancer control interventions for PLWH by leveraging existing HIV treatment and prevention infrastructure. Specifically, this NOFOsolicits applications that will identify, understand, and develop strategies to address barriers to the adoption, integration, and sustainability of evidence-based cancer control interventions among PLWH in LMICs and generate data in LMICs that can inform effective and equitable implementation of evidence-based cancer control for PLWH worldwide. Responsive applications should include multi-disciplinary teams of researchers with expertise in HIV, cancer, and implementation science to address the cancer control needs of PLWH populations specific to the proposed LMIC context.

Applications closing deadline: 15 December 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-033.html

Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 – Clinical Trial Optional)

The purpose of this NOFO is to solicit Research Project Grant (R01) applications for up to 3 years of support to develop and test interventions to reduce the impact of HIV-associated stigma on the prevention and treatment of HIV infection and/or AIDS, and on the quality of life of People Living with HIV and/or AIDS (PLWH). The NOFO will also support interventions to address the multiple intersecting stigmas and measurement of the stigmas at individual levels. Specifically, this initiative will support intervention research on a) novel stigma reduction strategies that link to increase in care-seeking behavior and/or decrease in transmission, b) reducing the impact of stigma on adolescent and/or youth health, c) strategies to cope with the complex burden of stigmatization due to HIV and one or more comorbidities/coinfections, d) reducing the effects of stigma on, and/or by, family members or caregivers of PLWH and e) development of innovative and improved stigma measurement in the context of implementation of a stigma-reduction intervention. The overall goals are to understand how to reduce stigma as a factor in HIV transmission, to eliminate or mitigate the aspects of stigma that limit beneficial health outcomes for the infected and at-risk individuals and communities, and to conduct exploratory studies to determine the feasibility of stigma-reduction interventions related to HIV prevention, treatment and/or care in Low and Middle-Income Countries (LMICs).

Applications closing deadline: 20 December 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-190.html

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Applications appropriate to this FOA should be consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR).

Applications closing deadline: 7 January 2024

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-068.html

 

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Studies that move the science of HIV and aging into new directions with little or no preliminary data are appropriate for this activity code. Applications appropriate for this FOA should be consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR).

Applications closing deadline: 7 January 2024

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-069.html

 

Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NIDA R25 program is to support training and educational activities for responsible analyses of complex large-scale data involving brain, behavioral, genomic, and socioenvironmental data that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs.

• Courses for Skills Development
• Curriculum or Methods Development

Applications closing deadline: 8 February 2024

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-027.html

 

Fellowships and Scholarships

 

Call for Mentors for the AAS Mentorship Programme

The AAS has set up a Mentorship Programme, a platform where young researchers are guided and supported to thrive in their careers to ultimately become the next generation of research leaders. Experienced professionals are encouraged to apply as Mentors and support talented early-career researchers across Africa. For more information email mentorship@aasciences.africa

Deadline for submissions is 30 September 2023.

For more information, click: https://mentorship.aasciences.africa/

 

Call for applications – Short Stay Research Fellowships 2023

Africa Platform of Ghent University Association

The Africa Platform of Ghent University Association (GAP) welcomes applications for visiting fellows. As one of the six regional platforms at Ghent University, GAP facilitates and fosters academic collaboration between Ghent University Association and academic institutions in Africa. The Africa Platform hosts five visiting research fellows every year. Awardees will spend a minimum period of two weeks at Ghent University or one of the associated University Colleges.

 Short Stay Research Fellowships

The Africa Platform fellowships are aimed at postdoctoral researchers (junior or senior lecturers and professors) who are affiliated with an African higher education or research institution. A bilateral agreement or memorandum of understanding needs to be in place between Ghent University and the African institution. An overview of agreements and MoUs can be found here. With any questions in this regard, please contact Annelies.Verdoolaege@UGent.be.

Applications closing deadline: 1 October  2023

For more information click: https://www.africaplatform.ugent.be/call-applications-short-stay-research-fellowships-2023

 

Wellcome Early-Career Awards

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding that could improve human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.

Applications closing deadline: 5 October 2023

For more information click: https://wellcome.org/grant-funding/schemes/early-career-awards

 

Call for Applications: 2024 OWSD-Elsevier Foundation Awards

Prizes for early career women scientists in water, sanitation and hygiene

The applicant must be a woman who has received her PhD in a scientific discipline within the previous ten years and whose current scientific research is related to the area of water, sanitation and hygiene.

Applications closing deadline: 8 October 2023

For more information click: https://owsd.net/call-applications-2024-owsd-elsevier-foundation-awards

 

Announcing the Global Health Equity Scholars Fellowship

The Global Health Equity Scholars (GHES) Fellowship is a 12-month, NIH-supported, mentored training in global health research designed to address health inequities and improve population health. Hosted by a consortium of Yale University, Stanford University, University of Arizona, and UC Berkeley, the fellowship year typically runs July-June and offers training opportunities in 24 countries. The fellowship is designed for US doctoral students (PhD, DrPH, etc.), US professional students (MD, DDS, DVM, PharmD, etc.), US postdoctoral fellows, and foreign postdoctoral fellows from affiliated institutions in LMICs. The program’s main objective is to train new generations of health researchers and professionals who will be prepared to address the emerging challenges in global health and inequity. These may include health challenges that arise from the world’s burgeoning human settlements known as slums that have developed in urban and rural communities of many LMICs.

Applications closing deadline: 1 November 2023

For more information click: https://globalhealth.stanford.edu/programs/fogarty-ghes/

 

The Schlumberger Foundation Faculty for the Future fellowships

Faculty for the Future fellowships are awarded to women from developing and emerging economies who are preparing for PhD or post-doctoral study in Science, Technology, Engineering and Math (STEM) disciplines to pursue advanced graduate study at top universities in their disciplines abroad. Launched by the SLB Foundation in 2004, Faculty for the Future has grown to become a community of 863 women from 90 countries. The long-term goal of the Faculty for the Future program is to generate conditions that result in more women pursuing scientific disciplines. Grant recipients are therefore selected as much for their leadership capabilities as for their scientific talents, and they are expected to return to their home countries to continue their careers and inspire other young women. Faculty for the Future grants range from USD 25,000 to 50,000 per year for PhD courses and a maximum of USD 40,000 for postdoctoral studies. Grants may be renewed through to completion of studies subject to performance, self-evaluation and recommendations from supervisors. The amount of the grant awarded depends on the actual costs of studying and living in the chosen location. Eligibility criteria and application process instructions can be found at New and Renewal Grant Application Processes.

Applications closing deadline: 10 November 2023

For more information click: https://www.facultyforthefuture.net/about-program/

 

African Career Acceleration Fellowships

The Crick Africa Network (CAN) is offering African Career Acceleration Fellowships supported by LifeArc for early-career biomedical scientists to develop translational scientific programmes and become independent scientists. We’re looking for ambitious early-career African scientists who can demonstrate strong scientific and leadership potential, a keen interest in translational science, and a commitment to establishing their own research groups and continuing their careers on the African continent. Our priority areas include

• diseases caused by viruses such as HIV, HBV and SARS-CoV-2,
• bacteria such as Mycobacterium tuberculosis and Mycobacterium ulcerans,
• other bacterial pathogens including AMR-priority pathogens,

   that cause diseases such as typanosomiasis, malaria and cryptospoidiosis,

  • helminths, and
  • other neglected tropical diseases.

  Applications to the second round of Crick Africa Network fellowships are now open until 12 November 2023.

  For more information click: https://www.crick.ac.uk/research/research-partnerships/strategic-partnerships/crick-africa-network/african-career-acceleration-fellowships

   

  NAEd/Spencer Postdoctoral Fellowship

  The Postdoctoral Fellowship supports early-career scholars working in critical areas of educational scholarship. Fellows will receive $70,000 for one academic year of research, or $35,000 for each of two contiguous years, working half-time. Fellows attend professional development retreats and receive mentorship from NAEd members and other senior scholars in their field. Applicants must have had their PhD, EdD, or equivalent research degree conferred between January 1, 2018, and December 31, 2022, to be eligible to apply this year. This fellowship is non-residential, and applications from all disciplines are encouraged. The NAEd/Spencer Postdoctoral Fellowship will fund 25 early-career researchers for the 2024-25 academic year.

  Applications closing deadline: 15 November 2023

  For more information click: https://naeducation.org/naedspencer-postdoctoral-fellowship-program/

   

  Wellcome Career Development Awards

  This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding that could improve human life, health and wellbeing.

  Applications closing deadline: 16 November 2023

  For more information click: https://wellcome.org/grant-funding/schemes/career-development-awards

  Wellcome Discovery Awards

  This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing.

  Applications closing deadline: 21 November 2023

  For more information: https://wellcome.org/grant-funding/schemes/discovery-awards

 

 

Mental Health Award: Finding the right treatment, for the right people, at the right time for anxiety and depression

This call aims to support validation of biological, psychological, social or digital markers to enable stratification in anxiety and/or depression as early as possible. Stratification will allow targeted treatment and ensure that the right people get the right treatment at the right time.

Applications closing deadline: 7 June 2023

For more information, click: https://wellcome.org/grant-funding/schemes/mental-health-award-finding-right-treatment-right-people-right-time-anxiety

 International Bioethics Research Training Program (D43 Clinical Trial Optional)

The overall goal of this initiative is to support the mentored training of a sustainable critical mass of bioethics scholars in low and middle-income country (LMIC) research intensive institutions with the capabilities to conduct original empirical or conceptual ethics research that addresses challenging issues in health research and research policy in these countries as well as provide research ethics leadership to their institutions, governments and international research organizations. FIC will support LMIC-U.S. collaborative institutional bioethics doctoral and postdoctoral research training programs that incorporate mentored research, advanced theoretical didactic courses and ethics career skills training components to prepare multiple individuals for positions of ethics scholarship and leadership in health research institutions in LMICs.

This Funding Opportunity Announcement (FOA) allows appointment of Trainees (D43)  proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

Applications closing deadline: 6 June 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-116.html 

HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery of candidate biomarkers or biomarker signatures for pain that can be used to facilitate the testing of non-opioid pain therapeutics in Phase II clinical trials. The biomarkers or biomarker signature will be developed through clinical research specifically focused on the identification of pain biomarkers or biosignatures that predict and/or monitor response to pain therapeutics. The resulting biomarkers or biomarker signatures may be focused on a single pain condition or on several pain conditions with common underlying pathophysiology. Applications to identify biomarkers or biomarker signatures that predict or monitor a therapeutic response across several related pain conditions should feature Multiple Principal Investigator (MPI)-led teams that represent each of the related pain conditions and associated clinical networks. The MPI-led teams are expected to decide upon a single set of measures or biomarker modalities including, but not limited to a combination of omics, Quantitative Sensory Testing (QST), actigraphy, Electroencephalography (EEG), digital measures, etc.as components of the biosignature for all pain conditions represented in the application. Applications should feature centralized resource groups that will coordinate clinical trials and standardize all sample or data collection methods, technology development, statistical analysis and algorithm development across the pain conditions under investigation.

Applications closing deadline: 10 July 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-018.html?utm_medium=email&utm_source=govdelivery 

 

 

For Expired funding opportunities:

  Click here